TGFBR1 and pancreatic neoplasm: In 2022, we studied the impact of berberine on lung metastasis in pancreatic cancer and found that berberine can function as a transforming growth factor-beta receptor 1 (TGFBR1) inhibitor, preventing pancreatic cancer cells from breaking through endothelial cells and metastasizing.